MDRF and Russia's Almazov Centre Partner for diabetes research
Chennai: The Madras
Diabetes Research
Foundation (
MDRF
) has signed a research collaboration with the
Almazov National Medical Research Centre
, based in Saint Petersburg, Russia.
The partnership will focus on developing new diagnostics and treatment strategies for diabetes, with an emphasis on
Gestational Diabetes Mellitus
(GDM).
It will also explore emerging areas such as artificial intelligence and
precision medicine
in diabetes care.
The memorandum of understanding (MoU) was signed by Dr. V. Mohan of MDRF and Prof. Evgeny Shlyakhto, Director General of the Almazov Centre.
The agreement includes training and exchange programs for medical specialists, joint conferences, academic meetings, collaborative publications, and educational and cultural exchanges.
Joint research projects on gestational diabetes have begun, involving Dr. Polina V. Popova and her team from Almazov's Endocrinology Department and Dr. Mohan's team at MDRF.
The collaboration is expected to expand further in the coming months.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
4 days ago
- Economic Times
Novo Nordisk's Wegovy enters India: Can this weight loss jab beat Mounjaro? Price, who can use it & how it works
Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy contains semaglutide, mimicking a hormone to control blood sugar and reduce hunger. Priced from Rs 17,345 to Rs 26,015 monthly, it showed significant weight loss in trials. Tired of too many ads? Remove Ads India's obesity market is growing fast Tired of too many ads? Remove Ads How Wegovy Works Wegovy India Price List Dose Monthly Price (Rs) Price Per Dose (Rs) 0.25 mg Rs 17,345 Rs 4,366 0.5 mg Rs 17,345 Rs 4,366 1 mg Rs 17,345 Rs 4,366 1.75 mg Rs 24,280 Rs 6,070 2.4 mg Rs 26,015 Rs 6,503 Mounjaro Dose Monthly Price (Rs) 2.5 mg Rs 14,000 5 mg Rs 17,500 Almost like weight loss surgery, but with a catch Wegovy vs Mounjaro: What's the Difference? Feature Wegovy (Semaglutide) Mounjaro (Tirzepatide) How it works Mimics GLP-1 hormone Acts on GLP-1 and GIP hormones Effect Lowers appetite, slows digestion Improves insulin and reduces appetite Approved for Weight loss Diabetes (off-label for weight loss) How to use Weekly injection via Flexpen Weekly injection via vial Price range Rs 17,345–Rs 26,015 Rs 14,000–Rs 17,500 In a big step for India's weight loss drug market, Danish pharmaceutical company Novo Nordisk has officially launched Wegovy , its much-talked-about weight loss injection. The company is now competing directly with Eli Lilly's popular drug, Mounjaro Wegovy is a once-a-week injection that comes in a pen-like device called FlexTouch. It's easy to use and doesn't require vials or syringes. According to Managing Director of Novo Nordisk India, Vikrant Shrotriya, the drug will be available in pharmacies across India by the end of June 2025, The Times of India has one of the world's highest numbers of people struggling with weight. Around 254 million people have general obesity and over 351 million suffer from belly fat-related issues. With the anti-obesity medicine market jumping from Rs 133 crore in 2021 to Rs 576 crore today (as per PharmaTrac), Novo Nordisk sees a huge said, 'Obesity is a chronic illness and a growing problem in India. Wegovy is easy to use and will be priced specially for Indian patients.'Wegovy contains a compound called semaglutide , which mimics a natural hormone in the body. This hormone helps control blood sugar, reduce hunger, slow digestion, and make you feel full for longer. While similar drugs like Ozempic are meant for diabetes, Wegovy is approved for long-term weight comes in a FlexTouch device, allowing users to adjust their weekly dose easily. Each monthly pack includes four needles. The medicine works on brain areas that manage appetite and food to Dr V. Mohan, a well-known diabetologist, 'Semaglutide not only helps in weight loss but also improves heart and inflammation markers. It's a strong option for Indian patients dealing with both obesity and rising heart risks.'For comparison, Eli Lilly's Mounjaro is slightly cheaper:Wegovy has shown very strong results. In global studies, people lost up to 15% of their weight on average, and some even lost 20%. It also helped lower the risk of heart attacks and strokes and improved liver the results are mostly maintained only if the person continues using the drug. If stopped, weight gain can return. Doctors also warn that muscle loss may happen over time, so people need to be regularly from TOI
India Today
5 days ago
- India Today
Wegovy weight-loss drug now in India: How it works and who should take it
Novo Nordisk, a Danish pharmaceutical company, has launched its weight-loss drug Wegovy in India. The drug, which contains semaglutide, works by regulating appetite and food intake, and is now the first medication in India approved for both long-term weight management and heart risk reduction in people who are overweight or WHAT EXACTLY IS WEGOVY, AND HOW DOES IT WORK?At its core, Wegovy is a once-a-week prescription-only injection that mimics a natural hormone in the body called GLP-1 (glucagon-like peptide-1). This hormone plays a key role in appetite regulation. When you take Wegovy, it binds to GLP-1 receptors in the brain, helping to reduce hunger, make you feel full sooner, lowers food cravings and helps control blood sugar biological mechanism makes it easier for people to stick to a lower-calorie diet without constantly feeling deprived—unlike traditional weight-loss methods that rely on sheer willpower THE SCIENCE BEHIND IT? The active ingredient in Wegovy is semaglutide, a compound also used in Novo Nordisk's type 2 diabetes drug Ozempic (not yet available in India). While Ozempic is meant for blood sugar control, Wegovy uses a higher dose of semaglutide (up to 2.4 mg) specifically for weight management and heart health. Wegovy is a once-a-week prescription-only injection that mimics a natural hormonein the body called GLP-1. () Clinical trials have shown that Wegovy, when combined with diet and physical activity, leads to:advertisementUp to 20% body weight reduction in 1 out of 3 people within about 68 weeks20% lower risk of major heart problems such as stroke, heart attack, and death related to cardiovascular disease, especially in people already living with heart conditions and obesityHOW IS WEGOVY TAKEN?Wegovy is administered using an easy-to-use injection pen once a week. It comes in five dosage strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 usually start with the lowest dose and gradually increase to the full dose of 2.4 mg under their doctor's MUCH DOES WEGOVY COST?The first three doses (0.25, 0.5, 1 mg) are priced at Rs 17,345 per month (about Rs 4,366 per week). The 1.7 mg is priced at Rs 24,280 per month and the 2.4 mg (full dose) costs Rs 26,015 for a company says this price structure is designed to make the drug more accessible as obesity cases rise across the THIS MATTERS FOR INDIAIndia has the third highest number of people living with obesity or overweight, according to a major 2023 study by the Indian Council of Medical Research and the Madras Diabetes Research Foundation. The report found that 254 million Indians, or nearly 29% of the population, are affected. The company says this price structure is designed to make the drug more accessible as obesity cases rise across the country. () Obesity is often misunderstood as a lifestyle issue, but experts say it's a chronic condition influenced by genetics, environment, biology, and mental health—not just food or exercise habits. It also increases the risk of over 200 diseases, including type 2 diabetes, heart disease, kidney and liver disorders, and certain SHOULD USE WEGOVY?Wegovy is a prescription-only drug meant for:Adults with a Body Mass Index (BMI) of 30 or higher, orAdults with a BMI of 27 or higher who also have a weight-related health conditionIt must be used under medical supervision, as it can cause side effects in some people, the company stated. "Obesity is not just a personal health concern, it's a national epidemic. Wegovy offers a proven, science-backed solution with the convenience of a user-friendly device. With India-specific pricing and the same cost for the first three doses, we are reinforcing our commitment to address the country's growing obesity burden," said Vikrant Shrotriya, Managing Director of Novo Nordisk like Wegovy and Mounjaro represent a new era in obesity treatment in India, offering hope to millions who struggle with weight and related health issues. By working with the body's natural hunger signals and showing benefits beyond just weight loss, it's more than a slimming aid—it's a chronic care always, people considering Wegovy should consult their doctor to understand whether it's the right fit for their health needs.- EndsMust Watch
India.com
14-06-2025
- India.com
How To Manage And Reduce The Risk Of Gestational Diabetes?
When a woman who was not previously diabetic develops high blood sugar levels during the second or third trimester of pregnancy, it is known as Gestational Diabetes Mellitus (GDM). If a woman aged 35 years or older has a history of Diabetes in their first degree relative like parents/siblings, has had Gestational Diabetes in a previous pregnancy, has delivered a large baby before, has Polycystic Ovarian Syndrome (PCOS), or has had multiple pregnancies. Also, certain ethnic groups, such as South Asians, and individuals with a sedentary lifestyle are also more prone to developing Gestational Diabetes during their pregnancy. Dr Farah Ingale, Senior Physician & Diabetologist, Director-Internal Medicine, Fortis Hiranandani Hospital Vashi shares how to manage and reduce the risk of gestational diabetes. GDM is mostly caused by hormonal changes happening in pregnancy that causes Insulin Resistance, genetic disposition can also be a cause for GDM. Classic symptoms of GDM include increased thirst, urination, fatiguability, wounds that do not heal, blurred vision, recurrent infections like of the urinary tract. Gestational Diabetes is diagnosed primarily through an Oral Glucose Tolerance Test (OGTT) and elevated blood sugar levels. Additional findings may include the presence of ketones in the urine, fetal macrosomia (a larger-than-average baby), or Polyhydramnios (excess amniotic fluid). GDM has long-term impact and complications that could impact both the foetus and the mother. If diagnosed with GDM. There is a 70 per cent risk of the mother developing Type 2 Diabetes Mellitus (T2DM), and certain metabolic syndromes and cardiovascular issues if GDM is left untreated. Children born to mothers with GDM also run the risk of developing T2DM as they grow older. They can also develop cognitive defects. GDM is also associated with increased risk of kidney disease and cancers. GDM can have a significant psychosocial impact due to the lifestyle and dietary restrictions an individual must follow. It may also lead to immediate and short-term complications for both the mother and the baby. Developing nations have been severely impacted by the growing burden of GDM. To tackle this silent crisis, we need to implement preventative strategies like lifestyle modifications and maintaining a normal weight by eating a healthy balanced diet and regular physical activity. Avoid being sedentary and remain stress free and also go for regular medical check-ups. Consult a doctor who can help make a diet chart for you depending on your body's needs. Consume foods with low Glycaemic Index (GI) as they release sugar into the blood stream slowly and do not lead to a sudden glucose spike. Foods that fall in that category are Quinoa, whole Wheat, Oats, brown Rice, Almonds, Walnuts, Flaxseeds, pulses. Practise portion control and abide by strict meal timings. For pregnant women, with a history of Diabetes or Obesity preconception counselling and testing is very important. Early detection and management can reduce the risk of adverse pregnancy outcomes. If necessary, insulin is the preferred medication for managing Gestational Diabetes. Maintaining good blood sugar control can significantly reduce or even prevent complications. Postpartum care is also a crucial aspect of overall management. --
